Literature DB >> 32475718

Understanding surgical decision-making in older adults with differentiated thyroid cancer: A discrete choice experiment.

Whitney Sutton1, Becky Genberg2, Jason D Prescott3, Dorry L Segev4, Martha A Zeiger5, Karen Bandeen-Roche6, Aarti Mathur3.   

Abstract

BACKGROUND: Prior studies demonstrated that older adults tend to undergo less surgery for thyroid cancer. Our objective was to use a discrete choice experiment to identify factors influencing surgical decision-making for older adults with thyroid cancer.
METHODS: Active and candidate members of the American Association of Endocrine Surgeons were invited to participate in a web-based survey. Multinomial logistic regression was utilized to assess patient and surgeon factors associated with treatment choices.
RESULTS: Complete survey response rate was 25.7%. Most respondents were high-volume surgeons (88.5%) at academic centers (76.9%). Multinomial logistic regression demonstrated that patient age was the strongest predictor of management. Increasing age and comorbidities were associated with the choice for active surveillance (P = .000), not performing a lymphadenectomy in patients with nodal metastases (relative-risk ratio: 2.5, 95% CI: 1.4-4.2, P = .002 and relative-risk ratio: 1.6, 95% CI: 1.2-2.1, P = .004, respectively), and recommending hemithyroidectomy versus total thyroidectomy for a cancer >4 cm (relative-risk ratio: 4.4, 95% CI: 2.5-7.9, P = .000 and relative-risk ratio: 3.4, 95% CI: 2.3-5.1, P = .000, respectively). Surgeons with ≥10 years of experience (relative-risk ratio: 3.3, 95% CI: 1.1-10.3, P = .039) favored total thyroidectomy for a cancer <4 cm, and nonfellowship trained surgeons (relative-risk ratio: 7.3, 95% CI: 1.3-42.2, P = .027) opted for thyroidectomy without lymphadenectomy for lateral neck nodal metastases.
CONCLUSION: This study highlights the variation in surgical management of older adults with thyroid cancer and demonstrates the influence of patient age, comorbidities, surgeon experience, and fellowship training on management of this population.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32475718      PMCID: PMC7704531          DOI: 10.1016/j.surg.2020.03.022

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  24 in total

1.  Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy.

Authors:  Iain J Nixon; Ian Ganly; Snehal G Patel; Frank L Palmer; Monica M Whitcher; Robert M Tuttle; Ashok Shaha; Jatin P Shah
Journal:  Surgery       Date:  2011-10-14       Impact factor: 3.982

2.  Understanding surgical decision making in early hepatocellular carcinoma.

Authors:  Hari Nathan; John F P Bridges; Richard D Schulick; Andrew M Cameron; Kenzo Hirose; Barish H Edil; Christopher L Wolfgang; Dorry L Segev; Michael A Choti; Timothy M Pawlik
Journal:  J Clin Oncol       Date:  2011-01-04       Impact factor: 44.544

3.  Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force.

Authors:  A Brett Hauber; Juan Marcos González; Catharina G M Groothuis-Oudshoorn; Thomas Prior; Deborah A Marshall; Charles Cunningham; Maarten J IJzerman; John F P Bridges
Journal:  Value Health       Date:  2016-05-12       Impact factor: 5.725

4.  Same thyroid cancer, different national practice guidelines: When discordant American Thyroid Association and National Comprehensive Cancer Network surgery recommendations are associated with compromised patient outcome.

Authors:  Mohamed Abdelgadir Adam; Paolo Goffredo; Linda Youngwirth; Randall P Scheri; Sanziana A Roman; Julie A Sosa
Journal:  Surgery       Date:  2015-10-02       Impact factor: 3.982

5.  Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.

Authors:  Allen S Ho; Michael Luu; Cynthia Zalt; Luc G T Morris; Irene Chen; Michelle Melany; Nabilah Ali; Chrysanta Patio; Yufei Chen; Jon Mallen St-Clair; Glenn D Braunstein; Wendy L Sacks; Zachary S Zumsteg
Journal:  Thyroid       Date:  2019-09-24       Impact factor: 6.568

6.  Extent of surgery affects survival for papillary thyroid cancer.

Authors:  Karl Y Bilimoria; David J Bentrem; Clifford Y Ko; Andrew K Stewart; David P Winchester; Mark S Talamonti; Cord Sturgeon
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

7.  Octogenarians have worse clinical outcomes after thyroidectomy.

Authors:  Zeyad T Sahli; Sheng Zhou; Omar Najjar; Oluwadamilola Onasanya; Dorry Segev; Allan Massie; Martha A Zeiger; Aarti Mathur
Journal:  Am J Surg       Date:  2018-04-22       Impact factor: 2.565

8.  Treatment patterns of aging Americans with differentiated thyroid cancer.

Authors:  Henry S Park; Sanziana A Roman; Julie Ann Sosa
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

9.  Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.

Authors:  R Michael Tuttle; James A Fagin; Gerald Minkowitz; Richard J Wong; Benjamin Roman; Snehal Patel; Brian Untch; Ian Ganly; Ashok R Shaha; Jatin P Shah; Mark Pace; Duan Li; Ariadne Bach; Oscar Lin; Adrian Whiting; Ronald Ghossein; Inigo Landa; Mona Sabra; Laura Boucai; Stephanie Fish; Luc G T Morris
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-10-01       Impact factor: 6.223

10.  Geriatric thyroidectomy: safety of thyroid surgery in an aging population.

Authors:  Melanie W Seybt; Sunny Khichi; David J Terris
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-10
View more
  1 in total

1.  Impact of the 2015 American thyroid association guidelines on treatment in older adults with low-risk, differentiated thyroid cancer.

Authors:  Whitney Sutton; Philip K Crepeau; Joseph K Canner; Shkala Karzai; Dorry L Segev; Aarti Mathur
Journal:  Am J Surg       Date:  2022-02-01       Impact factor: 3.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.